ArticleTranslational oncology2019

A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform.

Yoshito Tomimaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.